Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-02-07

Clinical Trial Update: Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating oral zileuton for moderate to severe facial acne vulgaris; the study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zileuton (zileuton)

Snippet

Sponsor: Critical Therapeutics | Conditions: Acne Vulgaris | Phase 2 | Status: UNKNOWN